In Vitro

, Volume 17, Issue 11, pp 979–984 | Cite as

Growth inhibition and morphologic modulation of human fibroblastlike cells by erythromycin

  • Andrew O. Martinez
  • Thomas H. Norwood
  • George M. Martin
Article
  • 16 Downloads

Summary

In vitro exposures of mass cultures and clones of human diploid fibroblastlike cells to erythromycin, in concentrations of 50 to 400 μg/ml, result in increasing degrees of growth inhibition and augmented cell volume, with a shift toward larger proportions of cells of the epithelioid type and fewer of the fibroblast type. These alterations were reversed upon subculture in the absence of the antibiotic.

Key words

erythromycin phenotypic modulation human fibroblastlike cells growth 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Teroka, H.. Reversal of the inhibitory action of chloramphenicol on the ribosomal peptidyl transfer reaction by erythromycin. Biochem. Biophys. Acta 213: 535–536; 1970.Google Scholar
  2. 2.
    Clark-Walker, G. D.; Linnane, A..In vivo differentiation yeast cytoplasmic and mitochondrial protein synthesis with antibiotics. Biochem. Biophys. Res. Commun. 25: 8–13; 1967.CrossRefGoogle Scholar
  3. 3.
    Adoutte, A.; Beisson, J.. Cytoplasmic inheritance of erythromycin resistant mutations inParamecium aurelia. Molec. Gen. Genet. 108: 70–77; 1970.PubMedCrossRefGoogle Scholar
  4. 4.
    Beale, G.; Knowles, A; Tait, A.. Mitochondrial genetics inParamecium. Nature 235: 396–397; 1972.PubMedCrossRefGoogle Scholar
  5. 5.
    Pious, D. A.; Hawley, P. Effect of antibiotics on respiration in human cells. Pediat. Res. 6: 687–692; 1972.PubMedCrossRefGoogle Scholar
  6. 6.
    Gray, J. E.; Purmalis, A.; Purmalis, B.; Mathews, J. Ultrastructural studies of the hepatic changes brought about by clindamycin and erythromycin in animals. Toxicol. App. Pharmacol. 19: 217–233; 1971.CrossRefGoogle Scholar
  7. 7.
    Dujovne, C. A.; Shoeman, D.; Branchine, J.; Lasagna, L. Experimental basis for the different hepatotoxicity of erythromycin preparations in man. J. Lab. Clin. Med. 79: 832–844; 1972.PubMedGoogle Scholar
  8. 8.
    Ginsburg, H.; Lagunoff, D.. Thein vitro differentiation of mast cells. J. Cell Biol. 35: 685–697; 1967.PubMedCrossRefGoogle Scholar
  9. 9.
    Kenny, G. E. Serological comparison of ten glycolytic mycoplasma species. J. Bacteriol. 98: 1044–1055; 1969.PubMedGoogle Scholar
  10. 10.
    Martin, G. M.. Use of tris (hydroxymethyl) amino-methane buffers in cultures of diploid human fibroblasts. Proc. Soc. Exp. Bio. Med. 116: 167–171; 1964.Google Scholar
  11. 11.
    Puck, T. T.; Marcus, P. I.; Cieciura, S. J. Clonal growth of mammalian cellsin vitro. J. Exp. Med. 103: 273–283; 1956.PubMedCrossRefGoogle Scholar
  12. 12.
    Klinger, H. P.; Hammond, D. O.. Rapid chromosome and sex chromatin staining with pinocyanol. Stain Technol. 46: 43–47; 1971.PubMedGoogle Scholar
  13. 13.
    Folkman, J.; Moscona, A.. Role of cell shape in growth control. Nature 273: 345–349; 1978.PubMedCrossRefGoogle Scholar

Copyright information

© Tissue Culture Association, Inc 1981

Authors and Affiliations

  • Andrew O. Martinez
    • 1
  • Thomas H. Norwood
    • 2
  • George M. Martin
    • 2
  1. 1.Department of Microbiology, School of MedicineThe University of New MexicoAlbuquerque
  2. 2.Division of Genetic Pathology, Department of Pathology and GeneticsThe University of WashingtonSeattle

Personalised recommendations